News
Eli Lilly (LLY) stock is sinking as investors react to concerns around GLP-1 drugs and industry dynamics. Red Brook Advisors managing partner Syed Husain joins Catalysts to discuss the market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback